SLC7A11 and neoplasm: Erastin treatment led to increased ChaC glutathione specific gamma-glutamylcyclotransferase 1 (CHAC1) staining and decreased recombinant solute carrier family 7, member 11 (SLC7A11) staining in sham tumor tissue (Supplementary Fig. 3) that were well responsive to erastin.